Panitumumab

Br J Clin Pharmacol. 2009 Oct;68(4):482-3. doi: 10.1111/j.1365-2125.2009.03492.x.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Apoptosis / drug effects
  • Cell Proliferation / drug effects
  • Colorectal Neoplasms / drug therapy*
  • ErbB Receptors / drug effects*
  • Humans
  • Panitumumab

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Panitumumab
  • ErbB Receptors